The American Chemical Society (ACS) and the Council for Chemical Research (CCR) will hold a special half-day symposium to address the critical challenge of keeping the US' chemical enterprise competitive, and the central role research and development (R&D) will play in this process.
Entitled 'Translational Chemical R&D: The Driving Force for Job Creation', the event is scheduled for August 22, during the ACS National Meeting & Exposition. The symposium will take place in Room 210A of the Boston Convention and Exhibition Center, and will include experts from the chemical enterprise. A private reception for further discussion with the speakers and other R&D leaders will follow the event.
The symposium will be divided into two sessions. In the first, presenters will explore big picture trends and new tools to maximise the impact of R&D. In the second session, presenters will focus on tools to translate R&D to commercialisation, such as open collaboration, venture investment in spin-offs, and R&D centers or hubs.
More than 8,000 reports on new advances in medicine, health, energy, environment, and other scientific disciplines that involve chemistry will be presented during the ACS National Meeting.
Search for more Conferences
Get customisable STM news alerts in your Mobile. Visit http://www.scopeknowledge.com/scoope.jar via your mobile browser to download the SCOOPE application
